000			03341cam a2200481Ka 4500
001			ocn776213422
003			OCoLC
005			20141103172221.0
006			m o d
007			cr cn|||||||||
008			120213s2012 cauaf ob 001 0 eng d
040			_aOPELS _beng _cOPELS _dOCLCQ _dOCLCF _dOCLCO _dKUK
020			_a9780123969620 (electronic bk.)
020			_a012396962X (electronic bk.)
035			_a(OCoLC)776213422
037			_a1126579:11178981 _bElsevier Science & Technology _nhttp://www.sciencedirect.com
050		4	_aRM666.P87 _bP76 2012
082	0	4	_a612/.01575 _223
049			_aTEFA
245	0	0	_aProtein engineering for therapeutics. _nPart B _h[electronic resource] / _cedited by K. Dane Wittrup, Gregory L. Verdine.
250			_a1st ed.
260			_aSan Diego, Calif. : _bAcademic, _c2012.
300			_a1 online resource (xliv, 348 p., [6] p. of plates) : _bill. (some col.)
490	1		_aMethods in enzymology ; _vv. 503
520			_aThis volume of Methods in Enzymology looks at Protein Engineering for Therapeutics. The chapters provide an invaluable resource for academics, researchers and students alike. With an international board of authors, this volume is split into sections that cover subjects such as Peptides, and Scaffolds Chapters provide an invaluable resource for academics, researchers and students alike. Iinternational board of authors. This volume is split into sections that cover subjects such as Peptides, and Scaffolds.
505	0		_aPart III: Peptides Stapled Peptides for Intracellular Drug Targets Mapping of vascular zip codes by phage display Engineering cyclic peptide toxins Peptide Discovery using Bacterial Display and Flow Cytometry Part V: Scaffolds Designed Ankyrin Repeat Proteins (DARPins): From research to therapy Target-binding proteins based on the tenth human fibronectin type III domain (10Fn3) Anticalins: small engineered binding proteins based on the lipocalin scaffold T Cell Receptor Engineering Engineering Knottins as Novel Binding Agents -- Part VI: Pharmacokinetics Practical Theoretic Guidance for the Design of Tumor Targeting Agents Re-Engineering Biopharmaceuticals for Targeted Delivery Across the Blood-Brain Barrier Engineering and Identifying Supercharged Proteins for Macromolecule Delivery into Mammalian Cells.
504			_aIncludes bibliographical references and index.
588			_aDescription based on print version record.
650		0	_aProteins _xTherapeutic use.
650		0	_aProtein engineering.
650		7	_aProtein engineering. _2fast _0(OCoLC)fst01079685
650		7	_aProteins _xTherapeutic use. _2fast _0(OCoLC)fst01079767
655		7	_aElectronic books. _2local
700	1		_aWittrup, K. Dane. _4edt
700	1		_aVerdine, Gregory L. _q(Gregory Lawrence) _4edt
710	2		_aScienceDirect (Online service)
776	0	8	_iPrint version: _tProtein engineering for therapeutics. Part B. _b1st ed. _dSan Diego, Calif. : Academic, 2012 _z9780123969620 _w(OCoLC)757491221
830		0	_aMethods in enzymology ; _vv. 503.
856	4	0	_3ScienceDirect _uhttp://www.sciencedirect.com/science/book/9780123969620 _zAn electronic book accessible through the World Wide Web; click for information
856	4	0	_3ScienceDirect _uhttp://www.sciencedirect.com/science/bookseries/00766879/503
942			_cEB
994			_aC0 _bTEF
999			_c21550 _d21550